Follow The Filings

CARL Carlsmed

Carlsmed earnings company data as of 4:01 PM ET 11/1

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CARL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CARL insider trades
  • None no insider bought on the open market
  • $2.6M sold by 1 insider outside a trading plan
  • $14K sold by 1 insider under 10b5-1 plans
  1. Jeffrey Bertolini COO
    Planned sale
    $11K 747 shares at $14.39 3.2% of stake
    Traded Oct 5 Filed Oct 6
  2. Jeffrey Bertolini COO
    Planned sale
    $3,400 243 shares at $13.99 1.1% of stake
    Traded Sep 30 Filed Oct 1
  3. Presidio Management Group XII, L.L.C. 10% owner, +2 joint filers
    Buy
    $3M 200,000 shares at $15.00 New stake
    Traded Jul 24, 2025 Filed Sep 15
  4. Michael Cordonnier CEO
    Sale
    $2.6M 197,855 shares at $13.29 13% of stake
    Traded Mar 2 Filed Mar 4

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants and 5 option exercises.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 1.01,2.03,9.01
8-K 2.02,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf